Immunology

COVID-19, COVID-19 news, Featured, Immunology, Pediatrics, World health
Omicron variant of SARS-CoV-2 associated with increased croup virus in children

Researchers at Boston Children’s Hospital have identified a link between increased prevalence of croup among children and the omicron variant of SARS-CoV-2. (Credit: Olga Siletskaya/Moment via Getty Images) The underlying

COVID-19, COVID-19 news, Featured, Immunology, Neuroscience, Post-COVID-19 syndrome, World health
Memory impairment and difficulties focusing among the symptoms COVID ‘long-haulers’ continue to face

A UC San Diego research team has revealed the neurological conditions that many people face months following infection by SARS-CoV-2. The first batch of data from the University of California

Cancer, Featured, Immunology, Medical News, Pollution, World health
Mechanism identified showing how air pollution affects lung tissue

Researchers at Nanjing University have identified a mechanism by which air pollutants affect the structure of lung tissue and increase cancer risk. According to a research published today in eLife,

Biotechnology, COVID-19, COVID-19 news, Immunology, Med Lifestyle, Medical News, Pharmaceuticals, Vaccine studies, World health
Inhalation-based vaccinations shown to provide long-lasting protection against SARS-CoV-2

The inhalation-based vaccine showed to be equally as effective as currently used COVID-19 vaccinations, at fractions of the current dose. Researchers from McMaster University have demonstrated that an inhalation-based COVID-19

Cancer, Gastroenterology, Immunology, Med Lifestyle, Medical News
Growth factor deficiency identified in TNF-induced inflammatory bowel disease

A Cornell research team has identified a new target for treatment in inflammatory bowel disease.

Immunology, Med Lifestyle, Medical News, Neurodevelopmental disorders, Neuroscience
Epstein-Barr virus suggested as leading cause of multiple sclerosis

After a longitudinal analysis found that those who had been previously infected with the Epstein-Barr virus (EBV) had a 32-fold increased risk of developing multiple sclerosis (MS), researchers are now